drugset / Trial / NCT00005039
Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer)
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized phase II trial to determine the effectiveness of vaccine therapy in treating patients who have advanced adenocarcinoma of the prostate (prostate cancer). Vaccines made from a person's prostate cancer cells may make the body build an immune response to kill tumor cells
Timeline
- Start
- 2000-01
- Primary completion
- 2007-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant fowlpox-prostate specific antigen vaccine | Vaccine | — | Intramuscular |
| Subject | recombinant vaccinia prostate-specific antigen vaccine | Vaccine | — | Other |